SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix®, Inc. (NASDAQ:AFFX) announced today at the Association of Molecular Pathology (AMP) conference that they have entered into an exclusive agreement with Genisphere®, LLC, to offer the company’s proprietary FlashTag™ Biotin HSR Reagents designed for Affymetrix. The miRNA reagents provide streamlined, high-fidelity target preparation methods yielding high quality data and unmatched reproducibility when used with the Affymetrix GeneChip® Arrays.
